Diagen is the company that currently owns the BPC-157 US patent (the European patent is expired), which was filed in 2012, approved in 2017 with an expected expiration of 2033
Erythromycin works as a prokinetic but loses effectiveness within weeks due to tachyphylaxis
Please note some who are purchasing their injection kits from overseas are receiving different syringes that have 40 units per 1cc/ml syringe (instead of 100 units per 1 cc) and my following instructions will NOT apply for these syringes see the bottom of this post- LESSON 4- for the proper dosing with these syringes
The fourth component, GHK-Cu, will be voted on in a subsequent February 2027 meeting HHS has announced that GHK-Cu is expected to return to Category 1 (after being moved to Category 2 in September 2023), which would restore compounding access for injectable formulations. The recommendations of the PCAC are non-binding but noteworthy
Do not flush medications down the toilet or pour them into drains
These areas have relatively thick skin with good barrier function
